Australia Botulinum Toxin Market Size & Outlook, 2023-2030
Australia botulinum toxin market, 2018-2030 (US$M)
Related Markets
Australia botulinum toxin market highlights
- The Australia botulinum toxin market generated a revenue of USD 152.8 million in 2023 and is expected to reach USD 295.9 million by 2030.
- The Australia market is expected to grow at a CAGR of 9.9% from 2024 to 2030.
- In terms of segment, type a was the largest revenue generating product in 2023.
- Type A is the most lucrative product segment registering the fastest growth during the forecast period.
Botulinum toxin market data book summary
| Market revenue in 2023 | USD 152.8 million |
| Market revenue in 2030 | USD 295.9 million |
| Growth rate | 9.9% (CAGR from 2023 to 2030) |
| Largest segment | Type a |
| Fastest growing segment | Type A |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Type A, Type B |
| Key market players worldwide | Ipsen SA, Merz Pharma, US WorldMeds, Galderma Group AG Registered Shares, Evolus Inc, Allergan, Metabiologics, Lanzhou Institute Of Biological Products |
Other key industry trends
- In terms of revenue, Australia accounted for 1.4% of the global botulinum toxin market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China botulinum toxin market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,443.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Botulinum Toxin Market Scope
Botulinum Toxin Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia botulinum toxin market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to botulinum toxin market will help companies and investors design strategic landscapes.
Type a was the largest segment with a revenue share of 98.89% in 2023. Horizon Databook has segmented the Australia botulinum toxin market based on type a, type b covering the revenue growth of each sub-segment from 2018 to 2030.
According to International Society of Aesthetic Plastic Surgery, in 2018, nearly 41,077 botulinum toxin, were performed in the country. Australia is among the top 10 countries with respect to expenditure on cosmetic procedures.
According to Victorian Cosmetic Institute, nearly USD 1 billion was spent on cosmetic procedures in 2017, with about USD 350 million spent on Botox procedures. In addition, the availability of facial injectable procedures at Fly-In-Fly-Out (FIFO) cosmetic clinics located across the country is anticipated to boost the market demand.
Nonsurgical procedures, such as anti-wrinkle treatments, microdermabrasion, and laser hair removal, are some of the most popular procedures among the Australian population, according to the Cosmetic Physicians College of Australasia (CPCA). High demand for cosmetic injectable treatment, increasing consumer spending, and the presence of advanced clinics is expected to boost the market growth.
Reasons to subscribe to Australia botulinum toxin market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia botulinum toxin market databook
-
Our clientele includes a mix of botulinum toxin market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia botulinum toxin market , including forecasts for subscribers. This country databook contains high-level insights into Australia botulinum toxin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia botulinum toxin market size, by product, 2018-2030 (US$M)
Australia Botulinum Toxin Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
